The biomarker identification process begins early in the drug discovery stage and helps build a strong biomarker testing strategy across all phases of development. Biomarker assays can serve to assess the activity of candidate therapeutics, and are used for validating targets, supporting the mechanism of action, predicting therapeutic efficacy, and alerting for potential toxicity. Biomarker assays create a knowledge framework for confident decision making to help minimize risk. Techniques include genomics, transcriptomics, proteomics, flow cytometry, and metabolomics.
Companies that sell Pharmaceutical Biomarker Testing and Services
Tags:
Please Login or Register to Create Tags